Mahmoud M Zakaria1, Safaa A Derbala1, Ayman E Salem2, Amgad E El-Agroudy1, Fatma M El-Tantawy3. 1. Faculty of Medicine, Urology and Nephrology Center, Mansoura University, Mansoura, 35511, Egypt. 2. Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, 35511, Egypt. 3. Faculty of Medicine, Urology and Nephrology Center, Mansoura University, Mansoura, 35511, Egypt. Fatma_201014@yahoo.com.
Abstract
BACKGROUND: Chronic kidney disease (CKD) is condition characterized by a gradual loss of kidney function, patient with CKD suffering from a variety of immune system defects. METHODS: This study looked at Fas, T cell, BCl2, and P53 activity in people with CKD, end stage renal disease (ESRD), and stable controls. RESULTS: The CD4+ and CD8+ levels in ESRD patients' peripheral blood were slightly lower than those in CKD patients. The CKD and ESRD groups had slightly higher Fas and FasL mRNA expression and slightly lower BCl2 mRNA gene expression than the normal control group (P < 0.05). P53 mRNA gene expression was shown to be higher in the patients than in the controls (P < 0.01). CONCLUSIONS: ESRD patients have a significantly lower number of T-cell subsets than CKD patients this is related to a higher degree of apoptosis in these cells.
BACKGROUND: Chronic kidney disease (CKD) is condition characterized by a gradual loss of kidney function, patient with CKD suffering from a variety of immune system defects. METHODS: This study looked at Fas, T cell, BCl2, and P53 activity in people with CKD, end stage renal disease (ESRD), and stable controls. RESULTS: The CD4+ and CD8+ levels in ESRD patients' peripheral blood were slightly lower than those in CKD patients. The CKD and ESRD groups had slightly higher Fas and FasL mRNA expression and slightly lower BCl2 mRNA gene expression than the normal control group (P < 0.05). P53 mRNA gene expression was shown to be higher in the patients than in the controls (P < 0.01). CONCLUSIONS: ESRD patients have a significantly lower number of T-cell subsets than CKD patients this is related to a higher degree of apoptosis in these cells.
Authors: Laura Casamayor-Polo; Marta López-Nevado; Estela Paz-Artal; Alberto Anel; Frederic Rieux-Laucat; Luis M Allende Journal: Crit Rev Clin Lab Sci Date: 2020-12-23 Impact factor: 6.250
Authors: Rebecca I Schleicher; Frank Reichenbach; Peter Kraft; Anil Kumar; Mario Lescan; Franziska Todt; Kerstin Göbel; Ingo Hilgendorf; Tobias Geisler; Axel Bauer; Marcus Olbrich; Martin Schaller; Sebastian Wesselborg; Lorraine O'Reilly; Sven G Meuth; Klaus Schulze-Osthoff; Meinrad Gawaz; Xuri Li; Christoph Kleinschnitz; Frank Edlich; Harald F Langer Journal: Blood Date: 2015-07-31 Impact factor: 22.113
Authors: Oleh Akchurin; Kelly Meza; Sharmi Biswas; Michaela Greenbaum; Alexandra P Licona-Freudenstein; Parag Goyal; Justin J Choi; Mary E Choi Journal: Kidney360 Date: 2021-01-28
Authors: Susan Hartzell; Sofia Bin; Chiara Cantarelli; Meredith Haverly; Joaquin Manrique; Andrea Angeletti; Gaetano La Manna; Barbara Murphy; Weijia Zhang; Josh Levitsky; Lorenzo Gallon; Samuel Mon-Wei Yu; Paolo Cravedi Journal: Front Immunol Date: 2020-09-29 Impact factor: 7.561